RxDoctor Payments Data

Lisa Blackwood

Dermatology · Lakewood, CONPI 1760749683

Payments from drug & device makers

$7,046in general payments, 2019–2025

Across 351 payments — averaging $20.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Regeneron Healthcare Solutions, Inc.$463
  • Novartis$446
  • Johnson & Johnson$410
  • Sanofi$341
  • Lilly USA, LLC$340
  • plus $3K from 22 others

What the payments were for

  • Food & beverage$6,75196%
  • Education$2954%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,046 in reported general payments places this provider in the 75th percentile of 280 dermatology providers in Colorado.

See all dermatology providers in Colorado

Medicare billing

Part B allowed, 2024
$153,535
Medicare patients
417
Services billed
2,907

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab14$52,777
AdbryTralokinumab-Ldrm12$46,704
Clobetasol Propionate52$1,804
ValacyclovirValacyclovir Hcl24$537
Fluorouracil12$516
Doxycycline Hyclate19$408
Ketoconazole21$401
Triamcinolone Acetonide37$394
Spironolactone11$295
Mupirocin44$287
Minoxidil27$233
Hydrocortisone35$201
Gabapentin20$107
Fluconazole11$39

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
LEO Pharma Inc.Adbry$333$46,70412 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 280 dermatology providers in Colorado.

Other dermatology in Lakewood

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →